Pan-and isoform-specific inhibition of Hsp90: Design strategy and recent advances
J Yu, C Zhang, C Song - European Journal of Medicinal Chemistry, 2022 - Elsevier
In the past few decades, the development of heat shock protein 90 (Hsp90) inhibitors for
cancer treatment has not stopped. About twenty compounds have been evaluated in the …
cancer treatment has not stopped. About twenty compounds have been evaluated in the …
[HTML][HTML] Targeting mitochondrial metabolic reprogramming as a potential approach for cancer therapy
L Zhang, Y Wei, S Yuan, L Sun - International Journal of Molecular …, 2023 - mdpi.com
Abnormal energy metabolism is a characteristic of tumor cells, and mitochondria are
important components of tumor metabolic reprogramming. Mitochondria have gradually …
important components of tumor metabolic reprogramming. Mitochondria have gradually …
[HTML][HTML] The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation
Binding of the mitochondrial chaperone TRAP1 to client proteins shapes bioenergetic and
proteostatic adaptations of cells, but the panel of TRAP1 clients is only partially defined …
proteostatic adaptations of cells, but the panel of TRAP1 clients is only partially defined …
[HTML][HTML] TRAP1 chaperones the metabolic switch in cancer
LA Wengert, SJ Backe, D Bourboulia, M Mollapour… - Biomolecules, 2022 - mdpi.com
Mitochondrial function is dependent on molecular chaperones, primarily due to their
necessity in the formation of respiratory complexes and clearance of misfolded proteins …
necessity in the formation of respiratory complexes and clearance of misfolded proteins …
[HTML][HTML] Mitochondrial metabolism in melanoma
C Huang, RH Radi, JL Arbiser - Cells, 2021 - mdpi.com
Melanoma and its associated alterations in cellular pathways have been growing areas of
interest in research, especially as specific biological pathways are being elucidated. Some …
interest in research, especially as specific biological pathways are being elucidated. Some …
[HTML][HTML] Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia
MAM Nelson, KL McLaughlin, JT Hagen, HS Coalson… - Elife, 2021 - elifesciences.org
Currently there is great interest in targeting mitochondrial oxidative phosphorylation
(OXPHOS) in cancer. However, notwithstanding the targeting of mutant dehydrogenases …
(OXPHOS) in cancer. However, notwithstanding the targeting of mutant dehydrogenases …
[HTML][HTML] The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting
TRAP1, the mitochondrial component of the Hsp90 family of molecular chaperones, displays
important bioenergetic and proteostatic functions. In tumor cells, TRAP1 contributes to shape …
important bioenergetic and proteostatic functions. In tumor cells, TRAP1 contributes to shape …
[HTML][HTML] Dynamically shaping chaperones. Allosteric modulators of HSP90 family as regulatory tools of cell metabolism in neoplastic progression
Molecular chaperones have recently emerged as fundamental regulators of salient
biological routines, including metabolic adaptations to environmental changes. Yet, many of …
biological routines, including metabolic adaptations to environmental changes. Yet, many of …
[HTML][HTML] The mitochondrial chaperone TRAP1 as a candidate target of oncotherapy
S Xie, X Wang, S Gan, X Tang, X Kang, S Zhu - Frontiers in oncology, 2021 - frontiersin.org
Tumor necrosis factor receptor-associated protein 1 (TRAP1), a member of the heat shock
protein 90 (Hsp90) chaperone family, protects cells against oxidative stress and maintains …
protein 90 (Hsp90) chaperone family, protects cells against oxidative stress and maintains …
Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives
TRAP1, the mitochondrial isoform of heat shock protein (Hsp) 90 chaperones, is a key
regulator of metabolism and organelle homeostasis in diverse pathological states. While …
regulator of metabolism and organelle homeostasis in diverse pathological states. While …